Mirum Pharmaceuticals (MIRM)
Commercializes rare-disease medicines while building a broader liver and genetic-disease pipeline.
$88.06
vs last close−3.33 (−3.64%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.53
Revenue estimate
$178.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.49−$0.30−$0.12$0.05−$0.11−$13.43−$1.06Pending
Estimate−$0.27−$0.39−$0.31−$0.10$0.02−$0.40−$0.74−$0.53
Surprise−81.5%+23.1%+61.3%+150.0%−650.0%−3,257.5%−42.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$99.4M$111.6M$127.8M$133.0M$148.9M$159.9M$176.2MPending
Estimate$96.6M$98.4M$130.1M$140.9M$142.5M$148.2M$166.3M$178.1M
Surprise+2.9%+13.4%−1.8%−5.6%+4.5%+7.9%+5.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.02 | — | — |
| Sep 2027 | −$0.25 | — | — |
| Jun 2027 | −$0.29 | — | — |
| Mar 2027 | −$0.33 | — | — |
| Dec 2026 | −$0.62 | — | — |
| Nov 2026 | −$0.53 | — | — |
| Aug 2026 | −$0.74 | −$1.06 | −42.8% |
| May 2026 | −$0.40 | −$13.43 | −3,257.5% |
| Feb 2026 | $0.02 | −$0.11 | −650.0% |
| Nov 2025 | −$0.10 | $0.05 | +150.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jul 2019 | |||
| Dec 2018 | |||
| Sep 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.02 | — | — | $217.3M | — | — | — |
| Sep 2027 | −$0.25 | — | — | $206.2M | — | — | — |
| Jun 2027 | −$0.29 | — | — | $197.2M | — | — | — |
| Mar 2027 | −$0.33 | — | — | $189.5M | — | — | — |
| Dec 2026 | −$0.62 | — | — | $183.8M | — | — | — |
| Nov 3, 2026 | −$0.53 | — | — | $178.1M | — | — | — |
| Aug 5, 2026 | −$0.74 | −$1.06 | −42.8% | $166.3M | $176.2M | +5.9% | −11.0% |
| May 6, 2026 | −$0.40 | −$13.43 | −3,257.5% | $148.2M | $159.9M | +7.9% | −6.5% |
| Feb 25, 2026 | $0.02 | −$0.11 | −650.0% | $142.5M | $148.9M | +4.5% | −15.1% |
| Nov 4, 2025 | −$0.10 | $0.05 | +150.0% | $140.9M | $133.0M | −5.6% | −1.2% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 9, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 9, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 28, 2019 | |||||||
| Jul 25, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 |